bg
N

Intellia (NTLA)

$000.00 0.00% ($0.00)

  • Today
  • Week
  • Month
  • Year
  • 5 Year
  • YTD
barakagetbaraka.com

About Intellia (NTLA)

Intellia Therapeutics, Inc. is a genome editing company. The Company is focused on developing therapeutics utilizing a biological tool known as CRISPR/Cas9. The CRISPR/Cas9 genome editing system includes two components: the Cas9 protein and the guide... Read more

  • USD26.98
  • USD28.23
  • USD26.61
  • USD47.48
  • -12.90%
  • 36M
  • 1.05M
  • 1.36M
  • 2.6B
  • 22.67
  • -27.30%

Unlock More Stock Analysis & Reports

Access detailed stock analysis from LSEG including analyst price target estimates.